Tandem Diabetes Care (TNDM) Capital Expenditures (2013 - 2026)

Tandem Diabetes Care (TNDM) has reported Capital Expenditures for 14 consecutive years, with $2.6 million the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Capital Expenditures fell 47.49% year-over-year to $2.6 million; the trailing twelve-month figure through Jun 2026 stood at $21.9 million (up 25.36% YoY), and the FY2025 full-year result was $19.9 million, up 3.73% from the prior year.
• Capital Expenditures retreated to $2.6 million in Q2 2026 per TNDM's latest filing, from $8.5 million in the prior quarter.
• Across five years, Capital Expenditures topped out at $13.7 million in Q3 2022 and bottomed at $2.6 million in Q2 2026.
• Historically, Capital Expenditures has averaged $6.2 million across 5 years, with a median of $5.3 million in 2023.
• The sharpest annual moves came in 2022 and 2023: Capital Expenditures surged 567.6% in 2022, then tumbled 60.61% in 2023.
• Over 5 years, Capital Expenditures stood at $5.6 million in 2022, then slipped by 7.61% to $5.2 million in 2023, then plunged by 40.97% to $3.1 million in 2024, then soared by 117.82% to $6.7 million in 2025, then slumped by 60.91% to $2.6 million in 2026.
• According to Business Quant data, Capital Expenditures over the past three periods registered $2.6 million, $8.5 million, and $6.7 million for Q2 2026, Q1 2026, and Q4 2025 respectively.